MADERA - What if a gentle swab of an infant's cheek was all it took to know if giving them a common antibiotic could also lead to long-term hearing loss?
That is what Valley Children's Precision Medicine Program is doing: the team is the first in the nation to use a revolutionary genetic test that can quickly let a doctor know if their tiny patient is at higher risk of hearing damage from an aminoglycoside. Once a doctor knows the baby has a particular version of a key hearing gene, they can choose a different course of care to treat an infection.